For additional information regarding sites, contact 844-687-8522 is a clinical research site located in New York, New York, United States 10022.
Crixeo Health Trust Score: 66/100 (FAIR). This profile has not yet been claimed by the site owner.
For additional information regarding sites, contact 844-687-8522 has participated in 7 clinical trials with 1 currently active.
Therapeutic areas: Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, Immunoglobulin A Nephropathy.
Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..
Trust Score: 66/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
For additional information regarding sites, contact 844-687-8522 has a Crixeo Trust Score of 66/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
For additional information regarding sites, contact 844-687-8522 has 7 clinical trials on record, with 1 currently active. Their work covers Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder, Immunoglobulin A Nephropathy.
For additional information regarding sites, contact 844-687-8522 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.